Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least seven days

Matthews, RP; Schurmann, D; Rudd, DJ; Levine, V; Fox-Bosetti, S; Zhang, S; Robberechts, M; Huser, A; Hazuda, DJ; Iwamoto, M; Grobler, JA

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017; 20 ( ): 122